agilon health (NYSE:AGL) Trading Up 8.5% Following Analyst Upgrade

agilon health, inc. (NYSE:AGL) shares were up 8.5% on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. Approximately 2,185,717 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 4,326,648 shares. The stock had previously closed at $2.82.

Several other brokerages also recently weighed in on AGL. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Needham & Company LLC started coverage on shares of agilon health in a report on Friday, January 10th. They issued a “hold” rating on the stock. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Macquarie started coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Finally, Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and upped their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $4.03.

Insider Activity

In related news, Director John William Wulf acquired 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 90,000 shares of company stock worth $198,100. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Oak Thistle LLC purchased a new position in shares of agilon health in the 4th quarter valued at approximately $25,000. Pines Wealth Management LLC purchased a new position in shares of agilon health in the 4th quarter valued at approximately $51,000. JPMorgan Chase & Co. raised its position in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Virtu Financial LLC purchased a new position in agilon health during the 3rd quarter worth approximately $120,000. Finally, Geode Capital Management LLC raised its position in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the last quarter.

agilon health Stock Up 8.5 %

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.26 billion, a PE ratio of -3.26 and a beta of 0.53. The business’s 50-day simple moving average is $2.07 and its 200-day simple moving average is $3.67.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the prior year, the business posted ($0.06) earnings per share. As a group, equities research analysts anticipate that agilon health, inc. will post -0.59 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.